- Nachrichtendetail
-
24.06.2024 09:04:27 - dpa-AFX: *TAKEDA GETS APPROVAL FOR LIVTENCITY IN JAPAN FOR REFRACTORY POST-TRANSPLANT CMV INFECTION/DISEASE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
TAKEDA PHARM.CO.LTD. | 853849 | Frankfurt | 24,180 | 02.07.24 10:36:05 | -0,150 | -0,62% | 24,140 | 24,340 | 23,960 | 24,330 |
